{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04326959",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CT/KLD/03/2020"
      },
      "Organization": {
        "OrgFullName": "PT. Prodia Stem Cell Indonesia",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid",
      "OfficialTitle": "Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid Regression: Immunohistochemistry, Histopathology and Imaging Study",
      "Acronym": "Keloid"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2020",
      "OverallStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 1, 2020",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 8, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 1, 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "March 26, 2020",
      "StudyFirstSubmitQCDate": "March 26, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 30, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "July 14, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 15, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "PT. Prodia Stem Cell Indonesia",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The clinical trial will be carried out at the Gatot Soebroto Army Central Hospital, Jakarta and planned from June 2020 to December 2020. Clinical trials of Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs) and Conditioned Medium Umbilical Cord-Mesenchymal Stem Cells (CM UC-MSCs) for Keloid were designed in three groups. Group 1 injected with The UC-MSCs at a dose of 2 million cells / cm3 using a 1 cc injection syringe (27G) by intra-lesion injection and booster with CM UC-MSCs at a dose of 1 cc / cm3 using a 1 cc injection syringe (27G) by intra-lesion injection and booster with CM UC-MSCs at the same dose 3 weeks later. Group 3 injected with Triamcinolon acetonide (TA) at a dose of 40 mg / cc / cm3 using 1 cc (27 G) syringe and booster with TA at 3 weeks later. The study subjects each group amounted to 7 patients suffering from Keloid. Patients were evaluated for 3 months after injection."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Keloid"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Keloid",
          "Allogeneic Mesenchymal Stem Cells",
          "Umbilical Cord",
          "Conditioned Medium"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "24",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "UC-MSCs + CM",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "A patient will be given UC-MSCs 2 million cells / cm3. After 3 weeks, the patient will be given CM 1 cc / cm3. The maximum size of Keloid is 15 cm per patient.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium",
                "Biological: Conditioned Medium"
              ]
            }
          },
          {
            "ArmGroupLabel": "CM + CM",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "A patient will be given CM 1 cc / cm3. After 3 weeks, the patient will be given CM 1 cc / cm3. The maximum size of Keloid is 15 cm per patient.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Conditioned Medium"
              ]
            }
          },
          {
            "ArmGroupLabel": "Triamcinolon acetonide",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "A patient will be given Triamcinolone acetonide 40 mg / cc / cm3. After 3 weeks the patient will be given Triamcinolone acetonide 40 mg/cc / cm3. The maximum size of Keloid is 15 cm per patient.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Triamcinolone Acetonide"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium",
            "InterventionDescription": "Injection of Allogeneic Umbilical Cord Mesenchymal Stem Cells 2 million cell/cm3 in Nacl 1 cc/million cell and booster with Conditioned Medium 1 cc/cm3 in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "UC-MSCs + CM"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Conditioned Medium",
            "InterventionDescription": "Injection of Conditioned Medium 1 cc/cm3 and booster with Conditioned Medium 1 cc/cm3 in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "CM + CM",
                "UC-MSCs + CM"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Secretome"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Triamcinolone Acetonide",
            "InterventionDescription": "Injection of Triamcinolone Acetonide 40 mg/cc/cm3 and booster in 3 weeks later. All treatment via intralesional injection. The maximum size of the keloid is 15 cm.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Triamcinolon acetonide"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Alfa SMA-1",
            "PrimaryOutcomeDescription": "Biomarker",
            "PrimaryOutcomeTimeFrame": "3 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Collagen type 1",
            "PrimaryOutcomeDescription": "Biomarker",
            "PrimaryOutcomeTimeFrame": "3 moth after injection"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Core Biopsy/Histopathology",
            "SecondaryOutcomeDescription": "Too evaluate histology of keloid",
            "SecondaryOutcomeTimeFrame": "3 month after injection"
          },
          {
            "SecondaryOutcomeMeasure": "Ultrasonography",
            "SecondaryOutcomeDescription": "To see image inside the body",
            "SecondaryOutcomeTimeFrame": "3 month after injection"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSurgery history of more than 3 months\nHas keloid that the maximum size is 15 cm and thickness is 3-5 mm\n\nExclusion Criteria:\n\nPatients with kidney failure\nPregnancy\nBreastfeeding\nLiver dysfunction\nBlood disorders\nCurrently receiving immunosuppressant therapy (chemotherapy or steroids)\nRefusing to participate in the study",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "55 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Anastasia Dessy Harsono, Master",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "087888363270",
            "CentralContactEMail": "anastasia.bedahplastik@gmail.com"
          },
          {
            "CentralContactName": "Cynthia Retna Sartika, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactEMail": "c.sartika@gmail.com"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007627",
            "ConditionMeshTerm": "Keloid"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000003095",
            "ConditionAncestorTerm": "Collagen Diseases"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          },
          {
            "ConditionAncestorId": "D000002921",
            "ConditionAncestorTerm": "Cicatrix"
          },
          {
            "ConditionAncestorId": "D000005355",
            "ConditionAncestorTerm": "Fibrosis"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9806",
            "ConditionBrowseLeafName": "Keloid",
            "ConditionBrowseLeafAsFound": "Keloid",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5312",
            "ConditionBrowseLeafName": "Cicatrix",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000014221",
            "InterventionMeshTerm": "Triamcinolone"
          },
          {
            "InterventionMeshId": "D000014222",
            "InterventionMeshTerm": "Triamcinolone Acetonide"
          },
          {
            "InterventionMeshId": "C000005900",
            "InterventionMeshTerm": "Triamcinolone hexacetonide"
          },
          {
            "InterventionMeshId": "C000030262",
            "InterventionMeshTerm": "Triamcinolone diacetate"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000893",
            "InterventionAncestorTerm": "Anti-Inflammatory Agents"
          },
          {
            "InterventionAncestorId": "D000005938",
            "InterventionAncestorTerm": "Glucocorticoids"
          },
          {
            "InterventionAncestorId": "D000006728",
            "InterventionAncestorTerm": "Hormones"
          },
          {
            "InterventionAncestorId": "D000006730",
            "InterventionAncestorTerm": "Hormones, Hormone Substitutes, and Hormone Antagonists"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000007166",
            "InterventionAncestorTerm": "Immunosuppressive Agents"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000004791",
            "InterventionAncestorTerm": "Enzyme Inhibitors"
          },
          {
            "InterventionAncestorId": "D000045504",
            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M16126",
            "InterventionBrowseLeafName": "Triamcinolone",
            "InterventionBrowseLeafAsFound": "Placement",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M16127",
            "InterventionBrowseLeafName": "Triamcinolone Acetonide",
            "InterventionBrowseLeafAsFound": "Occlusion",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M237968",
            "InterventionBrowseLeafName": "Triamcinolone hexacetonide",
            "InterventionBrowseLeafAsFound": "Occlusion",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M209570",
            "InterventionBrowseLeafName": "Triamcinolone diacetate",
            "InterventionBrowseLeafAsFound": "Occlusion",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M3369",
            "InterventionBrowseLeafName": "Anti-Inflammatory Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8199",
            "InterventionBrowseLeafName": "Glucocorticoids",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8941",
            "InterventionBrowseLeafName": "Hormones",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8940",
            "InterventionBrowseLeafName": "Hormone Antagonists",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9364",
            "InterventionBrowseLeafName": "Immunosuppressive Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infl",
            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}